S. 832 — Introduced in Senate

II 119th CONGRESS 1st Session S. 832 IN THE SENATE OF THE UNITED STATES March 4, 2025Mr. Tillis (for himself, Mr. Budd, Mrs. Blackburn, Mr. Daines, and Mr. Lankford) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. 1. Short title This Act may be cited as the Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. 2. Equalizing the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended— (1) by striking year, at least 7 and inserting “year— (I) for initial price applicability years 2026 and 2027, at least 7 ; and (2) by adding at the end the following: (II) for initial price applicability year 2028 and each subsequent initial price applicability year, at least 11 years will have elapsed since the date of such approval; and .